Abacavir Sulfate

Product NDC
51079-204
11-digit product format
510790204
Labeler code
51079
Product ID
51079-204_3a22f5ef-d757-6414-e063-6294a90af7de
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
abacavir sulfate
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Mylan Institutional Inc.
Application
ANDA091294
Marketing category
ANDA
Marketing start
2012-08-01
Substance
ABACAVIR SULFATE
Active strength
300 mg/1
Pharmacologic classes
Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A091294-001ABACAVIR SULFATEABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A091294-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-1884e616aacf4f…
2026-08-18 06:07:402026-07A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-1831067a03dcf5…
2025-08-23 18:47 UTC2025-08A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-186a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-1803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-182680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-185bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-1879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-181e350fbaab3a…
2024-05-31 18:47 UTC2024-05A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-188072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-185c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-185d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-184b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-1874a2ff9319b5…
2022-03-09 01:35 UTC2022-03A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-1887673890dc5c…
2021-03-12 10:30 UTC2021-03A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-185aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-188869cabd3fbd…
2020-11-12 02:37 UTC2020-11A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18c0c555d07b60…
2019-12-14 00:12 UTC2019-12A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-183f01610625f2…
2019-09-15 20:21 UTC2019-09A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18b00525d2431f…
2019-07-19 19:46 UTC2019-07A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-186a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-181c564ffb4f44…
2023-12-20 04:57 UTC2023-12A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-189b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-183f0d92c62455…
2023-05-13 08:27 UTC2023-05A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18053a50430f4f…
2023-01-26 05:58 UTC2023-01A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-183bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-183a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A091294-001ABACAVIR SULFATEEQ 300MG BASETABLET / ORALAB2012-06-18f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A091294-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A091294-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A091294-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A091294-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A091294-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A091294-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A091294-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A091294-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A091294-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A091294-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A091294-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A091294-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A091294-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A091294-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A091294-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A091294-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A091294-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A091294-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A091294-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A091294-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A091294-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A091294-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A091294-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A091294-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A091294-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A091294-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A091294-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A091294-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A091294-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A091294-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A091294-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A091294-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A091294-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A091294-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A091294-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A091294-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A091294-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A091294-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A091294-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A091294-001AB1f41ea6bd6efb…

Additional Listing Data#

Finished product
Yes
Brand name base
Abacavir Sulfate
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ABACAVIR SULFATE300 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
J220T4J9Q2Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
242679Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
80c1702a-973c-436a-90f8-69b29674dca0Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
aaa99659-c62c-7281-d402-9590409850c2Product name620260128
3832141c-c294-474a-9473-1052c891450eProduct name220230105
e1e3cf65-28b8-ebf3-c11f-d11a82e0862aProduct name420180604
af19b329-4f44-cd81-491a-fbb7fe7a079fProduct name220151013

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51079-204-01Abacavir Sulfate1 in 1 BLISTER PACKTABLET, FILM COATED113
51079-204-06Abacavir Sulfate50 in 1 CARTONTABLET, FILM COATED5013

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51079-204-01EA - Each51079-20459c1c5ad-9d65-4381-bb5b-b6fe2071618312013-02-13
51079-204-06EA - Each51079-204d02e28c3-156c-47cc-81bf-d498a009092012013-02-13

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51079-204ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.]12Current NDC, Legacy NDC, 2 package rows20220706_80c1702a-973c-436a-90f8-69b29674dca0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Abacavir SulfateABACAVIR SULFATESafecor Health, LLCf7633480-25aa-4326-bec9-82835b486a202026-03-05Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 091294
application number: ANDA091294
Abacavir SulfateABACAVIR SULFATEMylan Institutional Inc.80c1702a-973c-436a-90f8-69b29674dca02025-07-17Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 091294
application number: ANDA091294
ndc (product): 51079-204
Abacavir SulfateABACAVIR SULFATEMylan Pharmaceuticals Inc.5676d391-f9a4-44be-9604-954b3d8d0e2b2021-01-08Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 091294
application number: ANDA091294

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
242679abacavir 300 MG Oral TabletPSN80c1702a-973c-436a-90f8-69b29674dca013
242679abacavir 300 MG Oral TabletSCD80c1702a-973c-436a-90f8-69b29674dca013
242679abacavir (as abacavir sulfate) 300 MG Oral TabletSY80c1702a-973c-436a-90f8-69b29674dca013

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
51079-204-01510790204011 in 1 BLISTER PACKHistorical
51079-204-065107902040650 BLISTER PACK in 1 CARTON (51079-204-06) / 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-204-01) 50 blister pack2012-08-010000-00-00NoNoCurrent